 | UroGen Pharma Ltd. | |||
| NGM : URGN || Location: United States | ||||
$14.26+0.02 (+0.14%) |
0.31 M | 13.96 - 14.54 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 4.186 M |
| March 15, 2024 | 4.252 M |
| Feb. 29, 2024 | 3.935 M |
| Feb. 15, 2024 | 4.011 M |
| Jan. 31, 2024 | 3.258 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.69 | -0.72 | -3.81% |
| 09/30/2023 | -0.86 | -0.68 | 21.20% |
| 06/30/2023 | -1.16 | -1.03 | 11.11% |
| 03/31/2023 | -1.36 | -1.30 | 4.17% |
| 12/31/2022 | -1.09 | -1.22 | -11.44% |
URGN Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 34.122M | Shares Float | 24.372M |
| Short Float | 4.186M | Market Cap | 485.90M |
| Institution ownership | 70.50% | Insider ownership | 11.351% |
| Earnings Date | 05/09/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -3.55 | Forward EPS | -2.39 |